Filing Details
- Accession Number:
- 0001209191-21-003040
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-11 18:10:24
- Reporting Period:
- 2021-01-08
- Accepted Time:
- 2021-01-11 18:10:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1305253 | Eiger Biopharmaceuticals Inc. | EIGR | Biological Products, (No Disgnostic Substances) (2836) | 361004130 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1686952 | Iii C. Eldon Mayer | C/O Eiger Biopharmaceuticals, Inc. 2155 Park Boulevard Palo Alto CA 94306 | Ex Vp & Chief Commerc. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-01-08 | 1,690 | $11.68 | 35,810 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on January 31, 2020 for 7,500 shares.
Billionaire Hedge Funds
